Literature DB >> 28060040

Long-term Clinical and Radiologic Outcome in 500 Children With Parenchymal Neurocysticercosis.

Pratibha Singhi1, Renu Suthar, Brijendra Deo, Prabhjot Malhi, Niranjan K Khandelwal.   

Abstract

BACKGROUND: Our aim was to study long-term clinical and radiologic outcome in children with parenchymal neurocysticercosis (NCC) and its predictors.
METHOD: Five hundred children with NCC registered in the pediatric NCC clinic between January 1996 and December 2002 and followed till December 2009 were enrolled. Demographic details, clinical presentations and therapy received were recorded. Outcome was evaluated in terms of seizure recurrence and resolution of lesions on neuroimaging. Various factors that could influence outcome were studied.
RESULTS: Mean age at presentation was 8 ± 2.7 years, and the mean duration of follow-up was 8.8 ± 2.03 years; 79.6% (398) had single lesion, and 20.4% (102) had multiple lesions at presentation; 14.5% (58) of children with single lesion, and 28.4% (29) of children with multiple lesions had recurrent seizures (P < 0.001) during follow-up. At 6-month follow-up neuroimaging, resolution was seen in 52.7% (210) and 31.3% (32) of children with single and multiple lesions, respectively (P < 0.001). On prolonged follow-up, 94.6% (384) of single-lesion NCC and 88% (90) of multiple-lesion NCC (P < 0.001) had radiologic resolution. Single-lesion NCC, radiologic resolution and cysticidal therapy were associated with better seizure outcome (P < 0.05). Children with multiple lesions had significantly higher percentage of calcified lesions on long-term follow-up compared with those with a single lesion (11.7% vs. 3.6%, P < 0.05).
CONCLUSIONS: Children with a single-lesion NCC have favorable outcome with resolution of most of the lesions and few seizure recurrences. Cysticidal therapy leads to better seizure control and increased resolution of lesions on short-term follow-up.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28060040     DOI: 10.1097/INF.0000000000001536

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Microsurgical Treatment of Epilepsy with Parenchymal Neurocysticercosis.

Authors:  Yu-Tang Tan; Suo-Jun Zhang; Kai Shu; Ting Lei; Hong-Quan Niu
Journal:  Curr Med Sci       Date:  2019-12-16

2.  An Ambispective Cohort Study to Assess Seizure Recurrences in Children with Calcified Parenchymal Neurocysticercosis.

Authors:  Abhijit Modak; Renu Suthar; Indar Kumar Sharawat; Naveen Sankhyan; Jitendra Kumar Sahu; Prahbhjot Malhi; Niranjan Khandelwal
Journal:  Am J Trop Med Hyg       Date:  2019-10       Impact factor: 2.345

Review 3.  Taenia solium Cysticercosis and Its Impact in Neurological Disease.

Authors:  Hector H Garcia; Armando E Gonzalez; Robert H Gilman
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

4.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

5.  Epilepsy Outcomes and Hippocampal Volumes in Children with Multiple Parenchymal Neurocysticercoses.

Authors:  Shrimanth Yamasandi Siddegowda; Renu Suthar; Pratibha Singhi; Chirag Ahuja; Niranjan K Khandelwal; Naveen Sankhyan
Journal:  J Pediatr Neurosci       Date:  2021-07-02

6.  Intractable Epilepsy with Solitary Cerebral Calcification.

Authors:  Kyoung Jin Hwang; Jiyoung Kim; Eun Yeon Joo; Seung Bong Hong; Seung-Chyul Hong; Dae Won Seo
Journal:  J Epilepsy Res       Date:  2017-12-31

7.  Diagnosis and Treatment of Neurocysticercosis: 2017 Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).

Authors:  A Clinton White; Christina M Coyle; Vedantam Rajshekhar; Gagandeep Singh; W Allen Hauser; Aaron Mohanty; Hector H Garcia; Theodore E Nash
Journal:  Am J Trop Med Hyg       Date:  2018-04       Impact factor: 2.345

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.